A research team proposed a standardized benchmarking tool for clinical trial sites, designed to identify operational inefficiencies across recruitment, protocol adherence, and regulatory compliance. The framework combines 36 performance benchmarks developed with expert input across nine countries and is intended to let sites compare themselves against an operational ideal while accounting for differences by trial phase and therapeutic area, including oncology versus cardiology timelines.